Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


ALBINI EDWARD C Create: Alert

All | News | Filings
Date FiledTypeDescription
03/07/2023 4 ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns: Paid exercise price by delivering 6,588 shares @ $5.79, valued at $38.1k
Granted 47,000 options to buy @ $5.79, valued at $272.1k
Granted 31,500 restricted stock units @ $0
Exercised 9,125 restricted stock units @ $0
Exercised 8,750 restricted stock units @ $0
02/14/2023 4 ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns: Exercised 45,698 options to buy @ $5.808, valued at $265.4k
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns: Paid exercise price by delivering 2,151 shares @ $10.39, valued at $22.3k
Exercised 5,250 restricted stock units @ $0
09/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2020 4 ALBINI EDWARD C (CFO and Secretary) has filed a Form 4 on SUTRO BIOPHARMA, INC.
Txns: Granted 47,500 options to buy @ $10.09, valued at $479.3k
Granted 21,000 restricted stock units @ $0
09/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy